$50M in Philanthropy Elevates Basic Science Research
Over the course of its recent fundraising campaign, UCSF has now accrued a $100 million endowment for the UCSF Discovery Fellows Program, which supports basic science PhD students.
University of California San Francisco
Give to UCSFOver the course of its recent fundraising campaign, UCSF has now accrued a $100 million endowment for the UCSF Discovery Fellows Program, which supports basic science PhD students.
The newly named Sandler Program for Breakthrough Biomedical Research – previously known as the Program in Breakthrough Biomedical Research (PBBR) – has for 23 years supported the boldest, least explored research ideas in the life sciences.
Games and supplements claim to strengthen memory and cognition. Should you buy them?
Researchers at UCSF have demonstrated how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.
Three faculty members from UCSFhave been elected to the National Academy of Sciences (NAS), one of the highest honors accorded to American scientists.
The Alumni Association of UC San Francisco has named seven winners of the 2021 UCSF Alumni Achievement Awards.
The University of California shared the details of a proposed policy on COVID-19 vaccination as part of its engagement with its community as it joins the California State University in supporting immunizations as part of an expected return of students, faculty, academic appointees and staff to in-person instruction across the state this fall.
A new study suggests that the dangers posed by wildfire smoke may also extend to the largest organ in the human body, and our first line of defense against outside threat: the skin.
As part of ongoing efforts to make UC San Francisco a great place to work, UCSF will conduct its annual engagement survey of all staff from April 27 to May 21.
The study is the first comprehensive review of fatalities linked to the deadly chemical in the United States and identified more deaths than previously reported.
Scientists have figured out how to modify CRISPR’s basic architecture to extend its reach beyond the genome and into what’s known as the epigenome.